Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
Abstract Background Although tolvaptan treatment improves hyponatremia, only few studies have investigated whether tolvaptan actually benefits the survival of cirrhotic patients. This study evaluated the impact of tolvaptan on six-month survival of decompensated cirrhotic patients with and without h...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2018-09-01
|
| coleção: | BMC Gastroenterology |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s12876-018-0857-0 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|